Literature DB >> 19074865

Approaches to complex pathways in molecular epidemiology: summary of a special conference of the American Association for Cancer Research.

Duncan C Thomas1, James W Baurley, Elizabeth E Brown, Jane C Figueiredo, Alisa Goldstein, Aditi Hazra, Robin T Wilson, Nathaniel Rothman.   

Abstract

Entities:  

Mesh：

Year:  2008        PMID： 19074865     DOI： 10.1158/0008-5472.CAN-08-1690

Source DB:  PubMed          Journal:  Cancer Res        ISSN： 0008-5472            Impact factor:   12.701


× No keyword cloud information.
  9 in total

1.  Bayesian Pathway Analysis for Complex Interactions.

Authors:  James W Baurley; Anders Kjærsgaard; Michael E Zwick; Deirdre P Cronin-Fenton; Lindsay J Collin; Per Damkier; Stephen Hamilton-Dutoit; Timothy L Lash; Thomas P Ahern
Journal:  Am J Epidemiol       Date:  2020-12-01       Impact factor: 4.897

2. 

Authors:  Botao Fa; Chengwen Luo; Zhou Tang; Yuting Yan; Yue Zhang; Zhangsheng Yu
Journal:  EBioMedicine       Date:  2019-05-14       Impact factor: 8.143

Review 3.  Gene--environment-wide association studies: emerging approaches.

Authors:  Duncan Thomas
Journal:  Nat Rev Genet       Date:  2010-04       Impact factor: 53.242

4.  Pathway-based personalized analysis of cancer.

Authors:  Yotam Drier; Michal Sheffer; Eytan Domany
Journal:  Proc Natl Acad Sci U S A       Date:  2013-04-01       Impact factor: 11.205

5.  The regulatory landscape of retinoblastoma: a pathway analysis perspective.

Authors:  Laura Gómez-Romero; Diana E Alvarez-Suarez; Enrique Hernández-Lemus; M Verónica Ponce-Castañeda; Hugo Tovar
Journal:  R Soc Open Sci       Date:  2022-05-18       Impact factor: 3.653

Review 6.  Use of pathway information in molecular epidemiology.

Authors:  Duncan C Thomas; David V Conti; James Baurley; Frederik Nijhout; Michael Reed; Cornelia M Ulrich
Journal:  Hum Genomics       Date:  2009-10       Impact factor: 4.639

Review 7.  Methods for investigating gene-environment interactions in candidate pathway and genome-wide association studies.

Authors:  Duncan Thomas
Journal:  Annu Rev Public Health       Date:  2010       Impact factor: 21.981

8.  Exploratory biomarker analysis for treatment response in KRAS wild type metastatic colorectal cancer patients who received cetuximab plus irinotecan.

Authors:  Seung Tae Kim; Tae Jin Ahn; Eunjin Lee; In-Gu Do; Su Jin Lee; Se Hoon Park; Joon Oh Park; Young Suk Park; Ho Yeong Lim; Won Ki Kang; Suk Hyeong Kim; Jeeyun Lee; Hee Cheol Kim
Journal:  BMC Cancer       Date:  2015-10-20       Impact factor: 4.430

9.  Functional characterization of breast cancer using pathway profiles.

Authors:  Feng Tian; Yajie Wang; Michael Seiler; Zhenjun Hu
Journal:  BMC Med Genomics       Date:  2014-07-21       Impact factor: 3.063
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.